Current Pharmaceutical Design

Editor-in-Chief:

William A. Banks  
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA

Back

Abstract Ahead of Print

Genetic Polymorphisms and Zinc Status: Implications for Supplementation in Metabolic Diseases

Volume:24
Fabio Virgili, Roberto Ambra, Jacqueline McCormack, Elizabeth Ellen Simpson, Donatella Ciarapica, Lorenzo Barnaba, Elena Azzini and Angela Polito*

From Molecular Mechanism to the Etiology of Sjogren Syndrome

Volume:24
Wei Wei, Syed Sayeed Ahmad, Shuang Chi, Yu Xie, Mohammad Amjad Kamal and Jiang Li*

Single Probiotic versus Multiple Probiotics - A Debate in Current Scenario for Alleviating Health Benefits

Volume:24
Siva Kumar, Nagendra Sastry Yarla, Vijayendra Mishra, Mohamed Abdel Daim, Bechan Sharma, G M Ashraf, R Reggi , M Palmery, Ilaria Peluso* and Mohammad Amjad Kamal*

Influence of Hormones on Sjögren’s syndrome

Volume:24
Liu Yang, Wei Wei, Xi He, Yu Xie, Mohammad Amjad Kamal and Jiang Li*

Phytochemistry, traditional uses and pharmacological profile of rose hip: A review.

Volume:24
Zahra Ayati, Mohammad Sadegh Amiri , Mahin Ramezani , Elahe Delshad, Amirhossein Sahebkar* and Seyed Ahmad Emami

Should we consider lipoprotein (a) in cardiovascular disease risk assessment in patients with familial hypercholesterolaemia?

Volume:24
Panagiotis Anagnostis*, Pavlos Siolos, Dimitrios Krikidis, Dimitrios G. Goulis and John C. Stevenson

Pharmacology of PCSK9 inhibitors: Current status and future perspectives

Volume:24
Aikaterini N. Tsouka, Constantinos C. Tellis and Alexandros D. Tselepis*

Role of PCSK9 inhibitors in high risk patients with dyslipidemia: Focus on familial hypercholesterolemia

Volume:24
Vasilios Papademetriou*, Konstantinos Stavropoulos, Christodoulos Papadopoulos, Konstantinos Koutsampasopoulos, Kiriakos Dimitriadis and Kostas Tsioufis

The role of PCSK9 in the pathogenesis of non-alcoholic fatty liver disease and the effect of PCSK9 inhibitors.

Volume:24
Eleni Theocharidou*, Marianna Papademetriou, Andromachi Reklou, Alexandros Sachinidis, Chrisoula Boutari and Olga Giouleme

New horizons in the pathogenesis, pathophysiology and treatment of familial hypercholesterolaemia

Volume:24
Margus Viigimaa*, Silver Heinsar , Dragan Lovic, Alexandra Katsimardou, Alexia Piperidou and Davit Duishvili

Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia including Registries

Volume:24
Matilda Florentin, Michael S. Kostapanos, Moses S. Elisaf and Evangelos N Liberopoulos*

Drugs that mimic the effect of gene mutations for the prevention or the treatment of atherosclerotic disease: from PCSK9 inhibition to ANGPTL3 inactivation.

Volume:24
Vasilios G. Athyros, Niki Katsiki, Aikaterini Dimakopoulou, Dimitrios Patoulias, Sofia Alataki and Michael Doumas*

Multimodal treatment of homozygous familial hypercholesterolemia

Volume:24
Thomas Gossios*, Ioanna Zografou, Veta Simoulidou, Athina Pirpassopoulou, Konstantinos Christou and Asterios Karagiannis

Is very low LDL-C harmful?

Volume:24
Charles Faselis*, Konstantinos Imprialos, Haris Grassos, Andreas Pittaras, Manolis Kallistratos and Athanasios Manolis

Pharmacological Effects Of Carvacrol In Vitro Studies: A Review

Volume:24
Erika Ramos Silva, Fernanda Oliveira de Carvalho, Luciana Garcez Barretto Teixeira, Nayara Gomes Lima Santos, Fernanda Araujo Felipe, Hericalizandra Santa Rosa Santana, Saranavan Shanmugam, Lucindo Jose Quintans, Adriano Antunes de Souza Araujo and Paula Santos Nunes*

Nutraceutical-based integrative medicine: Adopting a Mediterranean diet pyramid for attaining healthy ageing in veterans with disabilities

Volume:24
Mario Ciccotti, Anna Raguzzini, Tommaso Sciarra, Giovina Catasta, Paola Aiello, Cosimo Buccolieri, Raffaella Reggi, Maura Palmery*, Florigio Lista* and Ilaria Peluso*

Autologous blood for conjunctival autograft fixation in primary pterygium surgery: A systematic review and meta-analysis.

Volume:24
Hossam Zein, Ammar Ismail, Mohamed Abdelmongy, Sherif Elsherif, Ahmad Hassanen, Basma Muhammad, Fathy Assaf, Ahmed Elsehili, Ahmed Negida, Shin Yamane, Mohamed M. Abdel-Daim* and Kazuaki Kadonosono

Role of p53 Gene in Breast Cancer: Focus on Mutation Spectrum and Therapeutic strategies

Volume:24
Raman Preet Kaur, Kanika Vasudeva, Roshan Kumar and Anjana Munshi*

Pharmaceutical potentialities of β-caryophyllene for drug delivery systems: a prospection

Volume:24
Pauline S. Santos*, Thaisa C. Oliveira, Luis Mário R. Júnior and Lívio C.C. Nunes